Medicare Part B vs. Part D
Drug companies are struggling with which reimbursement strategy to pursue. It
You may also be interested in...
An inspector General report takes the first public look at rebating under Medicare Par D.For Henry Waxman the message is that private negotiation isn't working to capture deep enough discounts. But the more important message for sponsors is that the report shows CMS remains firmly committed to the private sector drug insurance model.
Democrats are threatening to use a budgetary procedure to accelerate the passage of broad health reforms in the next Congress. Republicans are already voicing protest, particularly with the idea of a new government-run insurance plan gaining momentum. But those concerns may fall on deaf ears.
New e-prescribing standards under Medicare Part D were finalized in April, but doctors aren't rushing to swap their pen and pad for a PDA. However, a bill floating through Congress may jumpstart adoption of the technology by doctors--if the legislation can get into this year's Medicare bill.